FDA Drug recall D-1057-2017
Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By
- FDA Drug
- Class II
- terminated
- Published 2017-08-09
On 2017-08-09 the FDA classified a Class II recall of Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By by Pd Rx Pharmaceuticals, citing failed Tablet/Capsule Specification: out of specification for tablet weight.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1057-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-07-28 |
| Published | 2017-08-09 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pd Rx Pharmaceuticals |
| Distribution | US |
Product
Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30
Reason
Failed Tablet/Capsule Specification: out of specification for tablet weight.
Identifiers
| code_info | Lot: A17F55 Exp. 06/30/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1057-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.